Niagen Bioscience Changes Fiscal Year End
Ticker: NAGE · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Niagen Bioscience, Inc. (NAGE) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, fiscal-year-change
Related Tickers: CDXC
TL;DR
Niagen Bioscience (CDXC) is changing its fiscal year end to Dec 31.
AI Summary
Niagen Bioscience, Inc. filed an 8-K on March 19, 2025, reporting a change in its fiscal year end to December 31. The company, formerly known as ChromaDex Corp., is incorporated in Delaware and headquartered in Los Angeles, California.
Why It Matters
A change in fiscal year end can impact financial reporting schedules and investor expectations regarding earnings releases.
Risk Assessment
Risk Level: low — This filing is a routine administrative change and does not indicate any immediate financial distress or significant operational shift.
Key Numbers
- 1231 — Fiscal Year End (Updated to December 31)
Key Players & Entities
- Niagen Bioscience, Inc. (company) — Registrant
- ChromaDex Corp. (company) — Former company name
- March 17, 2025 (date) — Earliest event reported
- March 19, 2025 (date) — Date of report
- December 31 (date) — New fiscal year end
- Delaware (jurisdiction) — State of incorporation
- Los Angeles, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in the registrant's fiscal year end.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 17, 2025.
What is the new fiscal year end for Niagen Bioscience, Inc.?
The new fiscal year end for Niagen Bioscience, Inc. is December 31.
What was Niagen Bioscience, Inc. formerly known as?
Niagen Bioscience, Inc. was formerly known as ChromaDex Corp.
In which state is Niagen Bioscience, Inc. incorporated?
Niagen Bioscience, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Niagen Bioscience, Inc. (NAGE).